Clinical Trials in San Francisco

Showing 2861-2880 of 6,211 trials

Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines

NCT03014622

This is a safety and efficacy study of DaxibotulinumtoxinA for Injection to treat moderate to severe frown lines.

Revance Therapeutics, Inc.303 participantsStarted Dec 2016

Birmingham, Alabama, United States • Beverly Hills, California, United States • Newport Beach, California, United States +12 more locations

COMPLETEDPhase 3< 1 mile

A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)

NCT02425891

This multicenter, randomized, double-blind study evaluated the efficacy, safety, and pharmacokinetics of atezolizumab (MPDL3280A) administered with nab-paclitaxel compared with placebo in combination with nab-paclitaxel in participants with locally advanced or metastatic triple-negative breast cancer (TNBC) who have not received prior systemic therapy for metastatic breast cancer (mBC). The safety of single-agent nab-paclitaxel has been determined in previous studies of participants with mBC and the safety data to date suggest that atezolizumab can be safely combined with standard chemotherapy agents.

Triple Negative Breast Cancer

Hoffmann-La Roche902 participantsStarted Jun 2015

Birmingham, Alabama, United States • Springdale, Arkansas, United States • Oakland, California, United States +244 more locations

Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines

A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)

Find Trials by Condition in San Francisco

Study to Evaluate the Safety and Efficacy of CTP-543 in Adults With Moderate to Severe Alopecia Areata

A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Reveal LINQ Registry

Treg Adoptive Therapy for Subclinical Inflammation in Kidney Transplantation

Ovarian Aging in Low Grade Glioma (LGG) Treated With Temozolomide

A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Arthritis

PROCLAIM: Germline Genetic Testing for Prostate Cancer Patients

An Expanded Access Study to Provide at Home Subcutaneous Administration of Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Patients With HER2-Positive Breast Cancer During the COVID-19 Pandemic

Impact of Photobiomodulation (PBM) on Biomarkers of Alzheimer's Disease

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

Evidence for Health Improvement in People With Diabetes Using One Touch & Partner Solutions

Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise Only

A Clinical Trial of PRAX-114 in Participants With Major Depressive Disorder

A Study to Evaluate Androderm®'s Effect on Blood Pressure in Adult Hypogonodal Male Participants

OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone

Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis

INGEVITY+ Active Fixation Pace/Sense Lead Clinical Study

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD